Pleo Reb
FDA Label NDC 60681-3006

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Reb (NDC 60681-3006). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding indications, directions for use, dosage, ingredients, tamper evident, warning, principal display panel - 2 ml carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Indications

For temporary relief of occasional nausea and vomiting.

Directions For Use

Snap off top portion of sipping container. Insert glass sipping straw.

Dosage

1–3 × weekly 1 sip.

Ingredients

2 mL contains Peyer's Patches Extrakt 5X, in a base of purified saline solution.

Tamper Evident

Do not use this product if the glass vial is broken or if imprinted security strip on carton is torn.

Warning

If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.

Principal Display Panel - 2 Ml Carton

3006-1

Pleo™ Reb
PORTABLE SIPS 5X

Oral Homeopathic Medicine

INDICATIONS: For temporary relief of
occasional nausea and vomiting.

DIRECTIONS FOR USE: Snap off top
portion of sipping container. Insert glass
sipping straw.

DOSAGE: 1–3 × weekly 1 sip.

INGREDIENTS: 2 mL contains Peyer's
Patches Extrakt 5X, in a base of purified
saline solution. Tamper Evident: Do not
use this product if the glass vial is broken
or if imprinted security strip on carton is
torn.

convenient, disposable
single dose containers

50 doses, each 2 mL
(.06 fl oz)

Rev. 12/2008

Principal Display Panel (2 mL Carton)

Principal Display Panel (2 mL Carton)

* Please review the disclaimer below.